-
-
Login
EOFlow has secured a significant legal victory after a US appeals court overturned a $59.4 million judgment awarded to Insulet in the long-running dispute between the two patch pump manufacturers.
CamDiab’s automated insulin delivery technology gets regulatory progress toward fully closed-loop system.
News from Portal Diabetes that new medtech for an implantable insulin pump has reached an early regulatory milestone in the US.
FDA Commissioner Martin Makary recently highlighted the role of CGMs in preventing chronic conditions, questioning why they are only available on prescription. Could there be any benefit to the diabetes community of a policy change?
New medtech startup, Luna Health, based in the US, have raised $23.6 million to advance a patch pump designed specifically for overnight use only.
FDA approval of Simplera Sync sensor paired with MiniMed™ 780G insulin pump.
Latest news from key diabetes conference covering the latest in medtech, treatments, research and 'cures'.
Dexcom's financial filings reveal a warning letter from the FDA regarding processing in 2 of its manufacturing plants.
A new CGM launches this February in the UK.
News that Abbott and Dexcom have agreed not to sue each other for patents relating to their CGM tech for another 10 years.
Sana Biotechnology announce a significant step in the use of islet cells for T1D treatment that could pave the way to a T1D 'cure'!
